SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-19-020923
Filing Date
2019-10-23
Accepted
2019-10-23 16:35:35
Documents
6
Effectiveness Date
2019-10-23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82019_oramedpharma.htm S-8 97000
2 OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP. fs82019ex5-1_oramedpharma.htm EX-5.1 6112
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs82019ex23-2_oremedpharma.htm EX-23.2 3191
4 GRAPHIC image_001.jpg GRAPHIC 14930
5 GRAPHIC image_004.jpg GRAPHIC 3902
6 GRAPHIC image_006.jpg GRAPHIC 3828
  Complete submission text file 0001213900-19-020923.txt   139144
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: S-8 | Act: 33 | File No.: 333-234303 | Film No.: 191164156
SIC: 2834 Pharmaceutical Preparations